Desitin, leading producer of anti-epileptics, introduces Werum’s PAS-X Track & Trace

Fast implementation out of the box at Desitin’s plant in Hamburg, Germany / Regional and mid-sized pharma manufacturer benefits from comprehensive product-based functionality

Desitin’s headquarters in Hamburg, Germany. Source: Desitin Arzneimittel

Lüneburg, Germany, April 4, 2018 – Desitin Arzneimittel implements Werum’s PAS-X Track & Trace as serialization and aggregation solution at its plant in Hamburg, Germany. The company is a regional, mid-sized pharmaceutical manufacturer with leading positions in the treatment of neurological and psychiatric illnesses – especially epilepsy and Parkinson's syndrome. Desitin required a lean, powerful and easy to implement track-and-trace solution to comply with the anti-counterfeiting requirements of its various international target markets. These include all EU countries.

“We opted for Werum’s PAS-X Track & Trace solution as the connector between the shop floor and the serialization level because it meets all of our requirements,” says Daniel Weniger, Head of Process Engineering at Desitin Arzneimittel GmbH. “It is a proven serialization and aggregation solution that is already used successfully by many pharma and biotech manufacturers around the globe.”

Werum’s PAS-X Track & Trace solution is installed out of the box thus ensuring a short implementation time and safeguarding future upgrades. Initially the system covers two packaging lines and will be extended later.